Literature DB >> 25201055

Predictors of and barriers to service use for children at risk of ADHD: longitudinal study.

Kapil Sayal1, Jonathan Mills, Kate White, Christine Merrell, Peter Tymms.   

Abstract

Many children with, or at risk of, ADHD do not receive healthcare services for their difficulties. This longitudinal study investigates barriers to and predictors of specialist health service use. This is a 5-year follow-up study of children who participated in a cluster randomised controlled trial, which investigated school-level interventions (provision of books with evidence-based information and/or feedback of names of children) for children at risk of ADHD. 162 children who had high levels of ADHD symptoms at age 5 (baseline) were followed up at age 10 years. Using baseline data and follow-up information collected from parents and teachers, children who had and had not used specialist health services over the follow-up period were compared and predictors (symptom severity, comorbid problems, parental perception of burden, parental mental health, and socio-demographic factors) of specialist service use investigated. The most common parent-reported barrier reflected lack of information about who could help. Amongst children using specialist health services who met criteria for ADHD at follow-up, 36% had been prescribed stimulant medication. Specialist health service use was associated with each one-point increase in teacher-rated symptoms at baseline [inattention symptoms (adjusted OR = 1.40; 95% CI 1.12-1.76) and hyperactivity/impulsivity symptoms (adjusted OR = 1.23; 95% CI 1.05-1.44)]. Parental mental health problems were also independently associated with service use (for each one-point increase in symptoms, adjusted OR = 1.41; 95% CI 1.04-1.91). Severity of teacher-rated ADHD symptoms in early school years is a determinant of subsequent service use. Clinicians and teachers should be aware that parental mental health problems are independently associated with service use for children at risk of ADHD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25201055     DOI: 10.1007/s00787-014-0606-z

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  29 in total

1.  Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004.

Authors:  Kapil Sayal; Tamsin Ford; Robert Goodman
Journal:  Psychiatr Serv       Date:  2010-08       Impact factor: 3.084

2.  Impact of early school-based screening and intervention programs for ADHD on children's outcomes and access to services: follow-up of a school-based trial at age 10 years.

Authors:  Kapil Sayal; Victoria Owen; Kate White; Christine Merrell; Peter Tymms; Eric Taylor
Journal:  Arch Pediatr Adolesc Med       Date:  2010-05

3.  Underprivileged areas: validation and distribution of scores.

Authors:  B Jarman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

4.  Differential access to care for children with ADHD in special education programs.

Authors:  R Bussing; B T Zima; T R Belin
Journal:  Psychiatr Serv       Date:  1998-09       Impact factor: 3.084

5.  Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD.

Authors:  Philip Asherson; Keeley Brookes; Barbara Franke; Wai Chen; Michael Gill; Richard P Ebstein; Jan Buitelaar; Tobias Banaschewski; Edmund Sonuga-Barke; Jacques Eisenberg; Iris Manor; Ana Miranda; Robert D Oades; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

6.  Parent ratings of school behaviour in children at risk of attention deficit/hyperactivity disorder.

Authors:  K Sayal; E Taylor
Journal:  Acta Psychiatr Scand       Date:  2005-06       Impact factor: 6.392

7.  Identification of children at risk of Attention Deficit/Hyperactivity Disorder: a school-based intervention.

Authors:  Kapil Sayal; Heatha Hornsey; Stephen Warren; Fiona MacDiarmid; Eric Taylor
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-07-13       Impact factor: 4.328

8.  Use of medication by young people with attention-deficit/hyperactivity disorder.

Authors:  Michael G Sawyer; Joseph M Rey; Brian W Graetz; Jennifer J Clark; Peter A Baghurst
Journal:  Med J Aust       Date:  2002-07-01       Impact factor: 7.738

9.  The children's services interview: validity and reliability.

Authors:  Tamsin Ford; Helena Hamilton; Sabina Dosani; Lisa Burke; Robert Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-09-12       Impact factor: 4.328

10.  Pre-school hyperactivity/attention problems and educational outcomes in adolescence: prospective longitudinal study.

Authors:  Elizabeth Washbrook; Carol Propper; Kapil Sayal
Journal:  Br J Psychiatry       Date:  2013-08-22       Impact factor: 9.319

View more
  10 in total

1.  Preschool hyperactivity is associated with long-term economic burden: evidence from a longitudinal health economic analysis of costs incurred across childhood, adolescence and young adulthood.

Authors:  Maria Chorozoglou; Elizabeth Smith; Johanna Koerting; Margaret J Thompson; Kapil Sayal; Edmund J S Sonuga-Barke
Journal:  J Child Psychol Psychiatry       Date:  2015-06-13       Impact factor: 8.982

2.  Clinical service use as people with Attention Deficit Hyperactivity Disorder transition into adolescence and adulthood: a prospective longitudinal study.

Authors:  Hanna Eklund; Tim Cadman; James Findon; Hannah Hayward; Deirdre Howley; Jennifer Beecham; Kiriakos Xenitidis; Declan Murphy; Philip Asherson; Karen Glaser
Journal:  BMC Health Serv Res       Date:  2016-07-11       Impact factor: 2.655

Review 3.  What do parents perceive are the barriers and facilitators to accessing psychological treatment for mental health problems in children and adolescents? A systematic review of qualitative and quantitative studies.

Authors:  Tessa Reardon; Kate Harvey; Magdalena Baranowska; Doireann O'Brien; Lydia Smith; Cathy Creswell
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-01-04       Impact factor: 4.785

4.  Access to diagnosis, treatment, and supportive services among pharmacotherapy-treated children/adolescents with ADHD in Europe: data from the Caregiver Perspective on Pediatric ADHD survey.

Authors:  Moshe Fridman; Tobias Banaschewski; Vanja Sikirica; Javier Quintero; Kristina S Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-30       Impact factor: 2.570

5.  Barriers and predictors of medication use for childhood ADHD: findings from a UK population-representative cohort.

Authors:  A E Russell; T Ford; G Russell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

6.  Saudi mothers' perception of their children with attention-deficit hyperactivity disorder in Dammam, Al-Qatif, and Al-Khobar cities, Saudi Arabia.

Authors:  Zainab J Al-Mohsin; Heba A Al-Saffar; Shaher Z Al-Shehri; Marwa M Shafey
Journal:  J Family Community Med       Date:  2020-01-13

7.  Parent-perceived barriers to accessing services for their child's mental health problems.

Authors:  Anna Sofie Hansen; Gry Kjaersdam Telléus; Christina Mohr-Jensen; Marlene Briciet Lauritsen
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2021-01-29       Impact factor: 3.033

Review 8.  Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care.

Authors:  Raman Baweja; Cesar A Soutullo; James G Waxmonsky
Journal:  World J Psychiatry       Date:  2021-12-19

9.  Awareness of ADHD in primary care: stakeholder perspectives.

Authors:  B French; E Perez Vallejos; K Sayal; D Daley
Journal:  BMC Fam Pract       Date:  2020-02-28       Impact factor: 2.497

10.  Children With ADHD Symptoms: Who Can Do Without Specialized Mental Health Care?

Authors:  Birgit Levelink; Frans J M Feron; Edward Dompeling; Dorothea M C B van Zeben-van de Aa
Journal:  J Atten Disord       Date:  2018-02-22       Impact factor: 3.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.